Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Pharmacological treatment of COPD in the on-sint cohort

Lucía Marín Barrera, Cecilia López Ramírez, José Luis López-Campos, Carmen Calero Acuña, Alberto Fernández-Villar, Cristina Represas Represas, Cristina Ramos Hernández, Ricard Casamor
European Respiratory Journal 2014 44: P536; DOI:
Lucía Marín Barrera
1Unidad Médico-Quirúrgica de Enfermedades Respiratorias. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia López Ramírez
1Unidad Médico-Quirúrgica de Enfermedades Respiratorias. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Sevilla, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José Luis López-Campos
1Unidad Médico-Quirúrgica de Enfermedades Respiratorias. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Sevilla, Spain
2CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Calero Acuña
1Unidad Médico-Quirúrgica de Enfermedades Respiratorias. Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío, Sevilla, Spain
2CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Fernández-Villar
3Instituto de Investigación biomédica de Vigo (IBIV), Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Complexo Hospitalario de Vigo, Vigo, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Represas Represas
3Instituto de Investigación biomédica de Vigo (IBIV), Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Complexo Hospitalario de Vigo, Vigo, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cristina Ramos Hernández
3Instituto de Investigación biomédica de Vigo (IBIV), Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Complexo Hospitalario de Vigo, Vigo, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricard Casamor
4Departamento Médico de Novartis Farmacéutica, Novartis Farmacéutica, Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

OBJECTIVE:Describe pharmacological treatment of COPD in patients included in the On-Sint cohort, both when diagnosed and at present.

METHODS:Retrospective,multicenter observational study where patient data were collected from single medical visit and by reviewing medicals records.The cohort On-Sint was formed by adult COPD patients,smokers or ex-smokers(≥10 packs-years),who were regularly followed-up by 263 primary care physicians(PC) or 93 Pulmonologists(P).We describe and compare the pharmacological treatment(by therapeutic groups)that patients received upon diagnosis and at present stratified by the GOLD classification.Quantitative data expressed as mean(standard deviation)

RESULTS:1214 patients met inclusion criteria(age of 66.4(9.7)years,78.7% male,857(70.6%)by PC).The average time interval from diagnosis to inclusion was 8(7.2)years.The different therapeutic group that each patient received upon diagnosis and at present according to 2010 GOLD stages,is indicated in the table.

View this table:
  • View inline
  • View popup

CONCLUSIONS:On-Sint cohort has detected an increase in the use of LABD and ICS,although the indication seems to be more consistent with the functional severity.Mucolytics are still excessively used.The use of all groups of treatment is lower for those with unknown GOLD stage.

  • COPD - management
  • Treatments
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological treatment of COPD in the on-sint cohort
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pharmacological treatment of COPD in the on-sint cohort
Lucía Marín Barrera, Cecilia López Ramírez, José Luis López-Campos, Carmen Calero Acuña, Alberto Fernández-Villar, Cristina Represas Represas, Cristina Ramos Hernández, Ricard Casamor
European Respiratory Journal Sep 2014, 44 (Suppl 58) P536;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pharmacological treatment of COPD in the on-sint cohort
Lucía Marín Barrera, Cecilia López Ramírez, José Luis López-Campos, Carmen Calero Acuña, Alberto Fernández-Villar, Cristina Represas Represas, Cristina Ramos Hernández, Ricard Casamor
European Respiratory Journal Sep 2014, 44 (Suppl 58) P536;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
  • Long-term survivalaccording to Czech clinical phenotypes of COPD- Czech multicentre research database of severe COPD
  • Assessment of lung volumes and capacities in bronchodilator reversibility changes of hyperinflation of COPD
Show more 1.12 Clinical Problems - COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society